Research Use Only - Not for human consumption. 18+ only.
Research CompoundCognitive EnhancementSubcutaneousIntranasal

P21

Also known as: DTHFPIC Dipeptide

P21 is a nootropic peptide derived from CNTF (Ciliary Neurotrophic Factor). It promotes neurogenesis, especially in the hippocampus, and may improve learning and memory.

Research Status

Research Compound

Research compound

For research purposes only. Not approved for human use. Not medical advice.

Research Areas

Promotes hippocampal neurogenesis
Improves learning and memory
Neuroprotective effects
May enhance focus
Supports brain plasticity
Potential depression treatment

Side Effects

Headache
UncommonMild

May occur in the first 1-2 weeks as the peptide crosses the blood-brain barrier. Usually resolves with continued use. Stay well-hydrated and consider taking in the morning with food.

Mild fatigue or drowsiness
UncommonMild

Some users report initial fatigue as the brain adapts to increased neurogenic activity. Typically subsides within 2-3 weeks. Ensure adequate sleep and avoid driving if severely affected.

Injection site reactions
UncommonMild

Redness, mild itching, or small bruising at the injection site. Prevent by rotating sites and using proper injection technique. Apply ice if needed.

Mood elevation or mild euphoria
UncommonMild

Some users report improved mood or mild euphoria, likely due to increased hippocampal neurogenesis and BDNF signalling. This is generally considered a positive effect but should be monitored.

Vivid dreams or altered sleep patterns
UncommonMild

Increased neurogenesis and synaptic plasticity may enhance dream vividness or alter sleep architecture. Usually normalises after 2-4 weeks. Maintain consistent sleep hygiene.

Dizziness or lightheadedness
RareMild

Rare reports in early dosing phase. Sit or lie down if experienced. Ensure adequate hydration and food intake before injection.

Allergic reaction
RareSerious

Signs include rash, swelling of face/throat, difficulty breathing, or severe itching. Seek immediate medical attention. Discontinue use and inform healthcare provider of peptide use.

Dosing Reference

ParameterValue
Dose range10-20 mg
FrequencyDaily
TimingMorning
RouteSubcutaneous, Intranasal

Effects build over time. Take for 4-8 weeks for optimal results.

Research disclaimer

Figures drawn from published research literature and community logs. Not clinical recommendations. Consult a qualified professional. Research use only.

Reconstitution Guide

Do not use saline or bacteriostatic saline — use only bacteriostatic water for reconstitution

Do not shake the vial vigorously; gentle swirling prevents peptide degradation

Discard immediately if the solution appears cloudy, discolored, or contains visible particles

Use within 30 days of reconstitution when stored at 2–8°C

Do not freeze the reconstituted solution; freezing may denature the peptide

Use the PeptideVolt reconstitution calculator for your exact concentration

Use the PeptideVolt reconstitution calculator for your exact concentration

Molecular and Pharmacological Data

P21 is a synthetic peptide derived from Ciliary Neurotrophic Factor (CNTF) that crosses the blood-brain barrier and promotes neurogenesis, particularly in the hippocampus — the brain region critical for learning and memory formation. It activates neurotrophic signalling pathways that support the survival, growth, and differentiation of neurons, potentially enhancing synaptic plasticity and cognitive function over time.

CNTF Receptor Signalling

P21 mimics CNTF by binding to CNTF receptors on neural cells, activating the JAK-STAT and PI3K/Akt pathways, which promote neuronal survival and growth factor expression

Hippocampal Neurogenesis

Stimulates proliferation and differentiation of neural progenitor cells in the dentate gyrus of the hippocampus, increasing the number of functional neurons available for memory encoding

Synaptic Plasticity

Enhances long-term potentiation (LTP) and long-term depression (LTD) through increased BDNF expression and improved synaptic transmission, supporting learning and memory consolidation

  • P21 is a CNTF-derived peptide that crosses the blood-brain barrier, allowing direct access to neural tissue
  • Neurogenesis effects are most pronounced in the hippocampus, the primary brain region for declarative memory
  • Cognitive benefits typically require 4-8 weeks of consistent dosing as new neurons integrate into existing circuits
  • Animal models show improved performance on spatial learning and memory retention tasks
  • Effects are thought to be mediated by increased neurotrophic factor signalling and reduced neuroinflammation

Track your P21 research

Free account. No credit card required.

Start Free

Browse the Research Library

40+ peptide profiles with mechanism summaries, dosing data, and reconstitution guides.

View all peptides

Research Use Only. All content on this page is provided for informational and educational purposes related to scientific research. P21 is not approved for human use by the FDA or any equivalent regulatory body. This is not medical advice. Do not use any substance discussed here for therapeutic, diagnostic, or preventative purposes. Consult a qualified healthcare professional before making any health-related decisions. The Peptide Volt does not endorse the use of any research chemicals. 18+ only.